SHIREHAMPTON GROUP PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: L81008 | BRISTOL, BS11 9SB
Showing results 51-100 of 571
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Esomeprazole | 1,043 | 40.3K | £2.6K | +157.8% ▲ |
| Macrogol 3350 | 1,005 | 52.5K | £8.2K | +7.2% ▲ |
| Doxazosin mesilate | 990 | 38.2K | £1.5K | -7.3% ▼ |
| Doxycycline hyclate | 976 | 10.6K | £1.1K | +90.4% ▲ |
| Isosorbide mononitrate | 957 | 27.1K | £3.9K | +44.8% ▲ |
| Glucose blood testing reagents | 920 | 85.0K | £11.4K | +16.6% ▲ |
| Spironolactone | 918 | 20.2K | £4.4K | +70.3% ▲ |
| Quetiapine | 900 | 32.8K | £8.0K | +44.6% ▲ |
| Ferrous sulfate | 874 | 48.1K | £1.6K | +70.0% ▲ |
| Memantine hydrochloride | 836 | 17.8K | £3.2K | +153.1% ▲ |
| Flucloxacillin sodium | 832 | 34.0K | £1.7K | +85.0% ▲ |
| Desogestrel | 779 | 83.1K | £2.3K | +96.5% ▲ |
| Candesartan cilexetil | 767 | 29.8K | £1.3K | -35.4% ▼ |
| Ferrous fumarate | 760 | 55.3K | £2.3K | +4.9% ▲ |
| Finasteride | 756 | 21.2K | £785 | +15.4% ▲ |
| Levetiracetam | 755 | 41.6K | £3.1K | +64.9% ▲ |
| Hydrocortisone | 749 | 23.9K | £4.5K | +67.0% ▲ |
| Felodipine | 748 | 29.4K | £2.9K | +26.0% ▲ |
| 744 | 1,592 | £53.2K | +36.5% ▲ | |
| Docusate sodium | 743 | 42.8K | £3.0K | +100.4% ▲ |
| Edoxaban | 738 | 18.5K | £30.8K | +5.3% ▲ |
| Alendronic acid | 738 | 4,420 | £1.2K | -1.6% vs avg |
| Rivaroxaban | 733 | 17.7K | £11.7K | +19.8% ▲ |
| Zopiclone | 707 | 10.7K | £479 | +27.7% ▲ |
| Mometasone furoate | 688 | 793 | £6.2K | +71.4% ▲ |
| Venlafaxine | 685 | 34.8K | £6.3K | -18.9% ▼ |
| Nitrofurantoin | 682 | 7,550 | £5.5K | +42.9% ▲ |
| Olanzapine | 655 | 13.9K | £1.8K | +76.8% ▲ |
| Rosuvastatin calcium | 652 | 22.3K | £697 | -27.4% ▼ |
| Mirabegron | 652 | 14.8K | £13.6K | +62.3% ▲ |
| Fluticasone furoate/vilanterol | 618 | 1,033 | £24.5K | +299.2% ▲ |
| Cetirizine hydrochloride | 612 | 43.6K | £2.1K | +22.5% ▲ |
| Fexofenadine hydrochloride | 611 | 24.9K | £1.0K | -28.1% ▼ |
| Duloxetine hydrochloride | 605 | 22.6K | £2.4K | -4.8% ▼ |
| Famotidine | 590 | 13.4K | £7.7K | +20.9% ▲ |
| Gliclazide | 583 | 52.6K | £1.3K | -31.5% ▼ |
| Methotrexate | 579 | 11.7K | £12.8K | +77.9% ▲ |
| Cyanocobalamin | 578 | 29.4K | £3.0K | +63.7% ▲ |
| Umeclidinium bromide/vilanterol | 573 | 774 | £23.9K | +193.8% ▲ |
| Other health supplement preparations | 571 | 11.7K | £1.4K | +1,102.1% ▲ |
| Ibuprofen | 571 | 54.2K | £1.4K | +12.3% ▲ |
| Progesterone | 566 | 46.9K | £7.9K | +35.2% ▲ |
| Alginic acid compound preparations | 560 | 241.9K | £3.3K | -4.4% ▼ |
| Donepezil hydrochloride | 555 | 10.4K | £438 | +79.9% ▲ |
| 551 | 61.4K | £2.1K | +547.1% ▲ | |
| Lisinopril | 549 | 30.1K | £687 | -49.9% ▼ |
| Solifenacin | 540 | 21.5K | £1.1K | +13.2% ▲ |
| Montelukast | 532 | 14.8K | £720 | -22.3% ▼ |
| Letrozole | 529 | 13.0K | £1.2K | +183.3% ▲ |
| Empagliflozin | 521 | 17.9K | £22.2K | -16.7% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.